000

I-SENS, INC.

No trades
See on Supercharts

099190 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

i-SENS, Inc. engages in the development, manufacture and sales of medical sensors and measuring instruments based on electrochemical and biosensor technologies. It operates through the Blood Glucose Meter and Point-of-Care business divisions. The Blood Glucose Meter business division is composed of a diagnostic device that allows to measure the amount of glucose in the blood and consists of a blood glucose meter, blood glucose strip, and lancet. The Point-of-Care business division consists of diagnostic testing conducted at the patient’s site, rather than in a central laboratory. The company was founded by Geun-Sig Cha and Hak-Hyun Nam on May 4, 2000 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

099190 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company